ReVision Optics, Inc. and NovaMedica Sign Commercial Agreement to Market and Distribute Raindrop™ Vision Correction Technology in Russia

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MOSCOW--(BUSINESS WIRE)--NovaMedica, a Russian pharmaceutical and medical device company, and ReVision Optics, Inc., the U.S. developer of the innovative refractive surgery solution against presbyopia, Raindrop™ Near Vision Corneal Inlay, have signed an agreement to commercialize this technology in Russia.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC